Souare Sekouba (l), and Conde Doussou, (r) part of the WHO vaccine trial teams, run a final follow up with a participant. Follow ups monitor the health of everyone who is taking part in the trial, and are programmed for 3, 9, 21, 42, 63 and 84 days after the administration of the vaccine.
The World Health Organisation is running phase III clinical trials for Ebola virus disease vaccine in Guinea. The technique being used is "ring vaccination" which was used in the 1970s to eradicate smallpox.
- Sean Hawkey, all rights reserved
- Image Size
- 5616x3744 / 10.7MB
- Contained in galleries
- Ebola vaccine trial, Guinea